Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid CancerAlan L. Ho, James A. Fagin, Rébecca Leboeuf et al.|New England Journal of Medicine|2013Cited by 825
BRAFV600E Mutation Is Associated with Preferential Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibition in Thyroid Cancer Cell LinesRébecca Leboeuf, James A. Fagin|The Journal of Clinical Endocrinology & Metabolism|2008Cited by 124